The Greenville location houses primary manufacturing operations for the company’s biologic products sold in the United States. The company now offers a full line of synthetic bone grafts, human tissue products, traditional lumbar and cervical allograft, human demineralized bone matrix bone grafts and bone graft delivering accessories.
Related Articles on Orthopedic Devices:
Alphatec Spine Names Mark Francois Senior Director of Investor Relations
Stryker Pays $15M in Marketing Settlement
VG Innovations Releases Spine Device for Low Back Pain
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.